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The impact of computed high 
b-value images on the diagnostic 
accuracy of DWI for prostate 
cancer: A receiver operating 
characteristics analysis
Peigang Ning1, Dapeng Shi1, Geoffrey A. Sonn2, Shreyas S. Vasanawala  3, Andreas M. 
Loening  3, Pejman Ghanouni3, Piotr Obara3, Lewis K. Shin3,4, Richard E. Fan2, Brian A. 
Hargreaves3 & Bruce L. Daniel3
To evaluate the performance of computed high b value diffusion-weighted images (DWI) in prostate 
cancer detection. 97 consecutive patients who had undergone multiparametric MRI of the prostate 
followed by biopsy were reviewed. Five radiologists independently scored 138 lesions on native high 
b-value images (b = 1200 s/mm2), apparent diffusion coefficient (ADC) maps, and computed high 
b-value images (contrast equivalent to b = 2000 s/mm2) to compare their diagnostic accuracy. Receiver 
operating characteristic (ROC) analysis and McNemar’s test were performed to assess the relative 
performance of computed high b value DWI, native high b-value DWI and ADC maps. No significant 
difference existed in the area under the curve (AUC) for ROCs comparing B1200 (b = 1200 s/mm2) to 
computed B2000 (c-B2000) in 5 readers. In 4 of 5 readers c-B2000 had significantly increased sensitivity 
and/or decreased specificity compared to B1200 (McNemar’s p < 0.05), at selected thresholds of 
interpretation. ADC maps were less accurate than B1200 or c-B2000 for 2 of 5 readers (P < 0.05). This 
study detected no consistent improvement in overall diagnostic accuracy using c-B2000, compared with 
B1200 images. Readers detected more cancer with c-B2000 images (increased sensitivity) but also more 
false positive findings (decreased specificity).
Prostate cancer is the most common solid organ malignancy in American men, accounting for an estimated 
220,800 new cases and 27,540 deaths in 20151.
Transrectal ultrasonography (TRUS) remains the imaging modality of choice for prostate cancer diagnosis 
at biopsy, yet it performs poorly in identification of individual cancer foci. Multiparametric magnetic resonance 
imaging (mpMRI) clearly exceeds the performance of ultrasound in the detection of prostate cancer. MpMRI 
has a variety of important clinical applications including predicting reclassification among men who elect active 
surveillance(AS)2 and accurately localizing tumors prior to biopsy3,4. Pre-biopsy MRI enables image-targeted 
biopsy via direct MRI-guidance5or MRI-transrectal ultrasound (TRUS) fusion-guided biopsy6–8. These methods 
both improve diagnosis of clinically significant prostate cancer when compared to conventional biopsy methods.
MpMRI of the prostate includes T1- and T2-weighted anatomic imaging and functional MR techniques, 
including diffusion weighted imaging (DWI), dynamic contrast-enhanced imaging, and MR spectroscopic imag-
ing9. DWI is a functional imaging technique that probes tissue structures at the cellular level. It is one of the 
important components of the Prostate Imaging and Reporting Archiving Data System (PI-RADS). Normal glan-
dular prostate tissue on MRI gives no signal reduction on the ADC map and no increase in signal intensity on the 
high b-value images (PI-RADS 1). In contrast, aggressive prostate cancer gives a reduced signal on the ADC map 
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(dark) and focal hypersignal intensity on high b-value images (bright) (PI-RADS 4 or 5)10. The apparent diffusion 
coefficient (ADC) value of suspected tumor lesions, a parameter derived from DWI, can often predict not only 
the presence of prostate cancer but also the cancer grade11. ADC values have been shown to be a useful marker for 
predicting insignificant prostate cancer in candidates for AS12–14.
Despite its role as the most important component of mpMRI, DWI is limited by artifacts from physiologic 
motion, susceptibility, and chemical shift. These are compounded by inherent limitations in signal-to-noise ratio 
and image resolution. Improving DWI performance is an important goal that would improve the clinical utility 
of mpMRI.
While it is generally recognized that high b-value images are particularly important in prostate cancer identi-
fication, the optimal b-value for tumor detection remains controversial. Although higher b-values offer stronger 
diffusion-weighting and greater suppression of benign prostate tissue, thus potentially improving tumor con-
spicuity, these gains may be offset by reduced signal-to-noise ratio as well as increased susceptibility artifact and 
image distortion15. Computed high b-value DWI is a recently described technique in which DW images using 
very high b-values can be mathematically derived from lower b-value images, rather than directly acquired16. In 
a recent study of 49 patients with 2 radiologists, computed high b-value images increased sensitivity for detection 
of prostate cancer17. The purpose of this paper was to investigate the impact of computed high b-value imaging 
on image quality and tumor detection, including the impact on both sensitivity and specificity, in a study with 
multiple radiologists.
Results
Patient median age was 65 (Interquartile range = 4). Biopsy histopathology was available from targeted biopsy 
of all 138 lesions in the 97 patients. 77 lesions were benign and 61 were malignant on biopsy. The Gleason score 
of the malignant lesions ranged from Gleason 6 to Gleason 10. The most common Gleason score was 3 + 4 (25 
lesions). Details of the biopsy indication, prostate-specific antigen (PSA) level, lesions per patient, lesion size and 
lesion location are shown in Tables 1 and 2.
The AUCs and asymptotic 95% confidence interval for differentiating benign from malignant lesions using 
B1200, c-B2000 or ADC for each reader are shown in Table 3. AUC comparisons are shown in Table 4. No 
significant difference existed between the B1200 and c-B2000 AUCs for any of the 5 readers, as indicated by 
the complete overlap of corresponding AUC values for the B1200 images with the 95% confidence intervals for 
the c-B2000 images, and vice-versa, for every reader. For example, the ROC comparison of diagnostic accuracy 
using different DWI methods for Reader 1 in Fig. 1 showed nearly identical ROC curves for B1200 and c-B2000. 
While no differences were identified in diagnostic accuracy between B1200 and c-B2000, differences were seen 
between high b-value DWI and ADC for some readers. The AUC of B1200 exceeded that of ADC in 2 of 5 readers 
(p < 0.05). The AUC of c-B2000 exceeded ADC in 3 of 5 readers (p < 0.05) as shown in Table 4.
We also looked for significant differences in diagnostic accuracy between readers by comparing the AUC of 
their B1200 ROC curves. The AUC values for each reader fell in a narrow range from 0.821 to 0.859. No signifi-
cant differences were found between the readers; AUC values for each reader fell squarely within the 95% confi-
dence intervals of the other readers.
Given that previous authors have reported increases in sensitivity with computed high b-values, the sensitivity 
and specificity values of B1200 and c-B2000 were compared at different thresholds of interpretation provided by 
the 5-point rating scale. The four “operating-points” or interpretation thresholds were 1 vs. 2–5, 1–2 vs. 3–5, 1–3 
vs. 4–5 and 1–4 vs. 5. At each of these thresholds, sensitivity and specificity of each method were calculated and 
compared for B1200 and c-B2000 using McNemar’s test. These results are shown in Fig. 2 for all four operating 
points for all 5 readers (for a total of 20 points). In 4 of 5 readers there were significant increases in sensitivity 
Range Average Number(n)
Age (years) 45–79 64 ± 6
40–59(n = 23)
60–69(n = 56)
70–79(n = 18)
PSA (ng/mL) 0.6–63 10.7 ± 8.0
<4(n = 4)
4–10(n = 55)
>10(n = 38)
Lesions per patient 1–5 1.4 ± 0.8
1 lesion(n = 70)
2 lesions(n = 18)
3 lesions(n = 6)
4 lesions(n = 1)
5 lesions(n = 2)
Indication
No Prior Biopsy; Elevated PSA(n = 56)
Negative Prior Biopsy; Rising PSA(n = 37)
Active Surveillance for known Prostate Cancer(n = 42)
Staging for clinically significant Prostate Cancer(n = 1)
Other(n = 1)
Table 1. Study population characteristics. n: patient number; PSA: Prostate-Specific Antigen.
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and/or decreases in specificity with c-B2000 compare to B1200 (McNemar’s p < 0.05) at selected thresholds of 
interpretation (Fig. 2). As an example, the differences in sensitivity and specificity of B1200 vs. c-B2000 at the 
interpretation threshold of 1 or 2 vs. 3–5 are given in Table 5. Overall the average reader sensitivity for prostate 
cancer at this threshold increased from 61% to 75% while the corresponding specificity decreased from 92% to 
80%. Detailed data for other interpretation thresholds are not shown.
We identified 11 false-positive lesions where two or more readers scored the lesion as suspicious (score of 4 
or 5) on computed B2000 images but scored it as benign (score of 1, 2, or 3) on direct B1200 images. In these 11 
cases, pathology reports were unrevealing, and described the histologic pattern as “benign prostatic glands and 
stroma” in all 11 lesions. In one of these 11 lesions, one of 4 cores also showed some equivocal atypical small 
acinar cell proliferation but this one incidental finding was not enough to explain the false positives in our study. 
Of note, 9/11 of these lesions were located in the transition zone, including all five lesions where three or more 
readers scored a false positive.
Data were also analyzed to investigate whether c-B2000 images were more diagnostic of higher grade tumors 
than B1200 images. For this analysis, lesions were classified as “non-high grade lesions” (benign and Gleason 
3 + 3) versus “high-grade tumors” (Gleason 3 + 4, or higher). There were no significant differences in ROC AUCs 
between B1200 and c-B2000 for any of the readers (data not shown).
Discussion
The main results of this study are that computed very high b-value images (c-B2000) increase the sensitivity with 
which radiologists detect prostate cancer on DWI compared to native high b-value images (B1200). This study 
reports twice as many patients as the previous largest study17 and includes an ROC analysis of results from 5 
radiologists. But, the c-B2000 images also reduce the specificity with which radiologists exclude benign findings.
Diffusion-weighted MRI is a key part of both the first and second PI-RADS standards for interpretation of 
prostate MRI10,18. Numerous studies have shown that restricted diffusion is the single most reliable predictor 
Range Average Number(n)
Lesion size(mm) 5–40 13.3 ± 6.4
5–9(n = 46)
10–19(n = 73)
20–40(n = 19)
Lesion location in gland
L(n = 73); R(n = 65)
PZ (n = 63); TZ(n = 7); AFS(n = 5); ML(n = 69); SV(n = 2)
Apex(n = 32); Mid(n = 97); Base(n = 22);
Gleason score G 6 (n = 15); G 7 (n = 33); G 8 (n = 8); G 9(n = 4);G 10 (n = 1)
Table 2. Lesion characteristics. n: lesion number; L: left; R: right; PZ: peripheral zone; TZ: transition zone; AFS: 
anterior fibromuscular stroma; ML: median lobe; SV: seminal vesicle; G 6: Gleason 3 + 3; G 7: Gleason 3 + 4 and 
Gleason 4 + 3; G 8: Gleason 3 + 5 and Gleason 4 + 4; G 9: Gleason 4 + 5 and Gleason 5 + 4; G 10: Gleason 5 + 5.
B1200 c-B2000 ADC
95% Confidence Interval
B1200 c-B2000 ADC
Reader 1 0.821 0.818 0.726 [0.751,0.891] [0.748,0.888] [0.641,0.811]
Reader 2 0.832 0.798 0.717 [0.763,0.901] [0.742,0.872] [0.632,0.803]
Reader 3 0.842 0.824 0.823 [0.771,0.913] [0.750,0.897] [0.748,0.898]
Reader 4 0.859 0.904 0.807 [0.796,0.921] [0.850,0.958] [0.732,0.882]
Reader 5 0.846 0.815 0.807 [0.778,0.913] [0.742,0.889] [0.732,0.882]
Average 0.840 0.832 0.776
Table 3. AUCs of B1200, c-B2000 and ADC for Benign vs Tumor. B1200: b value = 1200 s/mm2, 
c-B2000:computed b value = 2000 s/mm2, ADC: apparent diffusion coefficient.
P value
B1200-c-B2000 B1200-ADC c-B2000-ADC
Reader 1 0.926 0.014* 0.009*
Reader 2 0.308 0.005* 0.014*
Reader 3 0.626 0.655 0.984
Reader 4 0.136 0.206 0.002*
Reader 5 0.230 0.353 0.824
Table 4. The AUC Comparison of B1200, c-B2000 and ADC for Benign vs Tumor. Asterisks indicate 
significance at p ≤ 0.05.
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of cancer on multi-parametric MRI. Some recent studies have proposed that imaging with very high b-values 
(b = 1500 mm2/sec or greater) may be most accurate19. In practice, FDA regulations, scanner hardware perfor-
mance, and imaging artifacts limit the achievable gradient slew rates, and peak gradient amplitude, which in turn 
lead to tradeoffs in very-high b-value DWI protocols. Standard DWI imaging with very high b-values suffers 
from longer echo times, increase T2-weighting, increased distortions, “ghosting” artifacts, and increased spatial 
blurring due to eddy currents during the echo-planar readout. Very high b-value DWI also requires substan-
tially longer scan time in order to obtain enough signal averages to compensate for the intrinsic reduction in 
signal-to-noise ratio that occurs with direct high b-value imaging.
Recently, computed diffusion-weighted images have been proposed as an alternative method to achieve images 
with similar contrast as native high b-value DWI, by extrapolating from images obtained with lower b-values20,21. 
Computed B1500 images improve the contrast between the high signal of prostate cancer and the normal back-
ground signal in the peripheral zone16,17. This increase in conspicuity of cancers translated to increased detection 
of prostate cancer; in a two-reader study comparing computed B1500 images with direct B1000 images in n = 49 
men who underwent radical prostatectomy, Rosenkrantz et al.17 found that computed B1500 images increased 
the sensitivity for prostate cancer from 46.9% to 69.4% and from 46.9% to 67.3% for reader 1 and 2, respec-
tively. Similarly, Grant et al.22 reported that cancer detection increased from 57/90 (63%) on direct B1000 images 
to 79/90 (88%) on computed B2000 images, using a multi exponential IVIM signal model. Bittencourt23 also 
detected 3 more cancers with computed high b-value images in a cohort of 24 patients. The results of our study 
agree with these previous studies. For example, as detailed in Table 5 in our study, using a reader rating of “slightly, 
clearly or markedly hyperintense to overall gland signal” (corresponding to a rating of 3, 4 or 5) as indicative of a 
positive test result, the average sensitivity for prostate cancer increased from 61% on direct B1200 images to 75% 
on c-B2000 images for five readers (p < 0.05 for 4 of 5 readers). Together the results of this study and the previous 
studies indicate that prostate cancer detection can be increased by post-processing to compute very high b-value 
images (Fig. 3).
Increased cancer detection does not necessarily imply an overall increase in diagnostic accuracy. It is impor-
tant to determine whether c-B2000 images improve overall discrimination of benign and malignant findings, or 
whether they increase detection of both true positives and false (Fig. 4). The largest previous studies reporting 
increased detection did not report on the impact of computed high b-value images on specificity17. Table 2 in the 
paper by Grant et al. suggests that false positives increased from 75/149 (50%) on direct B1000 images to 95/149 
(64%) on c-B2000 images22. In contrast, one small study of 10 patients found that sensitivity and specificity both 
increased from 89.4% and 87.5% to 96.0% and 96.6%, respectively with computed high b-value images16. Due to 
the uncertainty about the impact of cB2000 on specificity, our study was performed using a 5-point reader-rating 
scale, thereby enabling full ROC analysis of diagnostic accuracy of direct B1200 and computed B2000 images. 
The very similar shapes and lack of increased areas under the ROC curves for direct B1200 and computed B2000 
images for all 5 readers are consistent with the data from Grant et al.22 that computed high b-value images increase 
detection of both true and false positives, and indicate that computed high b-value images do not increase overall 
diagnostic accuracy. Most of the false positives on computed B2000 images were merely due to the overall lower 
repeatability of MRI in the transition zone, a well known phenomenon noted in numerous previous studies.
The results of the ROC analysis also confirm a somewhat higher diagnostic accuracy for B1200 as well as 
c-B2000 images compared to ADC map images, as supported by the higher ROC AUCs for c-B2000 images (aver-
age AUC 0.832) compared to ADC maps (average AUC 0.776) that was observed for all five readers (Table 3), 
and statistically significant for three of them (Table 4). This supports PI-RADS scoring schemes that recommend 
inspection of high b-value images, rather than merely reviewing ADC maps10,18.
Figure 1. ROC Comparison of Diagnostic Accuracy of DWI method for Reader 1. The ROC curves for B1200 
and c-B2000 are nearly identical.
www.nature.com/scientificreports/
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This study has several unique features compared to previous work. The DWI images were performed with a 
novel pulse sequence for reduced field-of-view diffusion MRI that provides high quality images with relatively lit-
tle distortion and blurring24 and were performed without use of an endorectal coil. Direct comparison with other 
Figure 2. Receiver operating characteristic curve analysis comparing the diagnostic accuracy of direct B1200 
diffusion-weighted prostate MR images with computed B2000 images in five readers. Open squares with 
dashed lines are from direct B1200 data. Solid squares with solid lines are from computed B2000 images. 
Arrows connect corresponding B1200 and cB2000 operating points when there is a difference in sensitivity 
and/or specificity that is significant by two-tailed McNemar’s test for comparisons of paired proportions, at 
a level of p < 0.05. Overall 12 operating points demonstrated different sensitivity and or specificity in 4 of 5 
readers. In reader 4 there were no significant differences between corresponding pairs of operating points at 
B1200 and computed B2000. The ROC curve areas and overall ROC curve shapes remained the same for all 
readers, indicating that despite changes in sensitivity and specificity for some readers at some thresholds of 
interpretation, overall computed B2000 images do not increase intrinsic diagnostic accuracy compared to direct 
B1200 images.
www.nature.com/scientificreports/
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DWI pulse sequences, including full field-of-view accelerated DWI, readout-segmented echo-planar imaging 
(EPI)25 and images performed with an endorectal coil was not possible in this retrospective study.
The study had several limitations. The retrospective design also limits the study. Although consecutive patients 
were included without regard to clinical indication, tumor size, etc., some selection bias is possible because 
B1200 images and ADC maps may have contributed to the original radiologist’s decision to select the lesions for 
MRI-TRUS fusion biopsy, but computed high b-value images did not. In addition, MRI-TRUS fusion biopsy was 
used as the gold standard for pathologic diagnosis because imaging targeting avoids potential mis-registration/
mis-assignment errors that may occur between prostatectomy specimens and pre-operative images. However, 
it is possible that some cancers were missed which could impact the results, particularly for small lesions. Also, 
24/121 (20%) of patients with available images and pathology were excluded because of unacceptable image 
quality. Finally, the very high b-value images were calculated using a mono exponential model16,17,23 but were 
not compared to other more complicated multi-exponential signal models incorporating Kurtosis or intravoxel 
incoherent motion (IVIM)22.
Sensitivity Specificity
B1200 c-B2000 p-value B1200 c-B2000 p-value
Reader 1 0.639 0.820 0.008* 0.909 0.922 0.705
Reader 2 0.541 0.689 0.039* 0.948 0.883 0.025*
Reader 3 0.721 0.918 0.001* 0.857 0.506 0.000*
Reader 4 0.541 0.607 0.346 0.935 0.857 0.083
Reader 5 0.607 0.721 0.052* 0.935 0.818 0.007*
Reader Average 0.610 0.751 0.917 0.797
Table 5. Comparison of Diagnostic Accuracy when a Rating 3, 4 or 5. (McNemar’s 2-tailed p-value. Asterisks 
indicate significance at p ≤ 0.05).
Figure 3. Examples of cases where Computed B-value increased the conspicuity of prostate cancer. (a) A small 
(8 mm) Gleason 4 + 4 tumor in the left latera peripheral zone of a 54 y/o man is faintly seen on B1200 images 
(left) but is more visible as a dominant abnormality compared to background variation in signal on computed 
B2000 images (center). (b) Simlarly, a large (40 mm) bilateral Gleason 3 + 3 tumor in the transition zones of a 
72 y/o man is also more consipicuous on computed B2000 images (center).
Figure 4. Example of false positive Computed B-2000 image. A small focal high signal area (10 mm) of the 
medial right peripheral zone of a 51 y/o man was most conspicuous on c-B2000 images (center arrow). TRUS-
fusion biopsy revealed only benign prostate glandular tissue, confirming that this finding was a false-positive 
abnormality on c-B2000.
www.nature.com/scientificreports/
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In summary, this study extends previous reports that computed high-b value images increase the sensitivity of 
clinical DWI for prostate cancer using a clinically relevant DWI protocol that does not require directly acquiring 
B2000 images in a larger number of patients interpreted independently by multiple radiologists, with image-directed 
biopsy as the gold standard. However, this increased sensitivity is accompanied by a commensurate increase in false 
positives. Rather than raising overall increase diagnostic accuracy, computed high b-value images are best described 
as moving radiologists to a more sensitive but less specific operating point on their DWI ROC curve.
Methods
Study design. This retrospective study was approved by Stanford’s institutional review board with a waiver 
of the requirement for written informed consent. We identified 153 consecutive patients who underwent mpMRI 
of the prostate followed by MRI–TRUS fusion biopsy. Our clinical practice was to use PI-RADS 1 and all lesions 
classified as PI-RADS 3, 4 or 5 during the initial clinical review of scans were targeted for biopsy. Pathology was 
only from MRI-TRUS fusion biopsies. Our MRI-TRUS fusion biopsies were performed at target locations on 
images. Those locations were used to direct radiologists where to provide their interpretations. We directed the 
radiologists to the lesion with a “line” on the images but not a contour or circle so as to avoid pre-biasing the 
radiologists about the potential extent of disease at any particular target location. All subjects with adequate DW 
imaging, available pathology, and multiple b-values including b = 50, 800 and 1200 s/mm2 were included. We 
excluded 56 subjects due to incorrect b-values on DWI or unavailable pathology result or moderate or severe 
artifact. In total, 97 patients with 138 MRI lesions were included (Fig. 5).
DWI. Diffusion weighted imaging of the prostate was performed using a 3 Tesla MR scanner (MR750, 
GE Healthcare, Waukesha, WI) and using an external 32 channel body array coil in prostate mode, without 
an endo-rectal coil. A dedicated small field-of-view spin-echo echo-planar sequence used a 2-dimensional 
Figure 5. Flow chart of patients included and excluded.
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radio-frequency pulse to selectively excite spins in a narrow rectangular strip of tissue, enabling higher reso-
lution prostate images with a shorter echo-planar read-out train. This achieves high resolution images of the 
prostate with minimal distortion24,26. A slice-selective refocusing pulse only refocuses on-resonant water spins, 
avoiding fat spins because they are not excited in the same slice. B-values of 0, 50, 800, 1200 sec/mm2 were used 
in all patients, using tetrahedral encoding. Number of signal averages was 12, 24, and 64 for b-values 50, 800, 
and 1200 respectively. Other scan parameters included TR/TE of 2000/54 ms, Field of view of 24 cm (frequency 
encoding direction) × 12 cm (phase encoding direction), Corresponding matrix (160 × 80), Slice thickness was 
4.0–4.2 mm, Fourteen slices were obtained through the prostate and seminal vesicles.
Imaging processing. DWI images were analyzed using open-source DICOM software Osirix (version 6.5 
64-bit, Pixmeo, Geneva, Switzerland), with the ADC plug-in “ADCmap” to calculate the ADC maps from the 
b = 50, 800 and 1200 s/mm2 source images by fitting the signal to a mono-exponential decay function: I (b) = I (0)
exp(−b*D) where I is the signal intensity, b is the b-value, and D is the diffusivity on a pixel-by-pixel basis. The 
same function was used with a b = 2000 s/mm2 to calculate the computed b2000 (c-B2000) images.
Overall, this protocol and imaging processing yielded three types of diffusion-dependent images which were 
used in the reader study: Native EPI-DWI with b = 1200 sec/mm2 (B1200), computed DWI at b = 2000 sec/mm2 
(c-B2000), and maps of the apparent diffusion coefficient (ADC maps).
Reader study. In order to maximize the generalizability of this study, five board-certified radiologists ana-
lyzed the images independently. These readers had 1, 2, 4, 4, and 7 years of experience reading prostate MRI. 
And they were body-MRI fellowship trained attendings (4) or board-eligible body-MRI fellowship trainee (1). 
The readers only interpreted the designated spots where biopsy was performed. The radiologists reviewed the 
images in 3 sessions, separated by at least 3 days, to minimize learning bias. During each session, each radiologist 
reviewed the B1200 images on one third of the lesions, c-B2000 images on the second third of the lesions, and 
ADC maps on the final third of the lesions. During the second session the radiologists reviewed c-B2000 images 
on the first third of the lesions, ADC maps on the second third of the lesions and B1200 images on the final third 
of the images. During the third session, the radiologists reviewed the ADC maps on the first third of the lesions, 
the B1200 images on the second third of the lesions, and the c-B2000 images on the final third of the images 
(Fig. 6). In this fashion, during each session, each radiologist reviewed every lesion once, with one of the three 
types of images. After completing all three sessions, each radiologist had reviewed every lesion 3 times, once with 
each type of image. This design was chosen to minimize the influence of the results from one type of images on 
a radiologists’ interpretation of the other types of images (learning bias), and to allow the diagnostic accuracy of 
each type of image to be independently assessed. A 5-point scoring system was used to score the images (shown 
in Table 6). While similar to PI-RADS version 118, this scale was used instead of the PI-RADS because it allows 
each method to be analyzed independently rather than integrating the interpretation of ADC and high b-value 
DWI images. We did not strictly follow PI-RADS v1 or PI-RAD v2 for the reader analysis because we wanted to 
specifically look at the diagnostic accuracy contribution of each type of images separately; the PI-RADS do not 
assign separate scores to the ADC and DWI images.
MedCalc Statistical Software (version 14.8.1; MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 
2014) was used for statistical analysis. Receiver operating characteristic (ROC) analysis and McNemar’s test of paired 
proportions was performed to assess the sensitivities and specificities of the B1200 images, c-B2000 images and ADC 
maps with distinguishing benign from malignant. Area under the ROC curve (AUC) was compared.
Figure 6. Flow chart of the reader study.
score B1200 and c-B2000 ADC
1 Normal. No increase in signal intensity (SI) No lesion
2 Focal, slightly hyper intense, but similar to overall heterogeneity Barely visible, similar to overall heterogeneity
3 Focal, dominant, slightly hyper intense compared to overall heterogeneity
Focal, slightly decreased ADC compared to 
overall heterogeneity
4 Focal, dominant, clearly hyper intense compared to overall heterogeneity
Dominant, Focal, Moderately decreased ADC 
compared to overall heterogeneity
5 Focal, dominant, markedly hyper intense with no competing heterogeneity
Dominant Focal, markedly low ADC, without 
significant heterogeneity elsewhere
Table 6. The 5-point scoring system for B1200, c-B2000 and ADC.
www.nature.com/scientificreports/
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